Kiwa Bio-Tech Products Group Corp (fka KWBT)

[umiak]

Sounds to me like they are doing what they can to keep expenses down.

The 8k is clear there are 2 things Paritz put in the 10k, going concern stuff and insufficient accounting practices. Both are common in sm caps. Growth in revenue shows good chance out doing expenses and beyond. If all was perfect would be double digit pps. Company has chosen to keep accounting as is due to cost, when they up list they will upgrade accounting staff.

If you see boogeyman better find a different investment. I see what one would expect for otc EXCEPT KWBT has big growth in revenue now, solid partner in expansion plan, and huge market growth ramp up over next 4 yrs. Those 3 conditions are enough to get and keep my attention in a positive way.